Adult mesenchymal stem cells (MSCs) have been suggested to decrease lymphocyte proliferation in vitro. We hypothesised that foetal MSCs (fMSCs) would have an immunosuppressive effect on allograft responses in vitro. Human MSCs were isolated and cultured from firsttrimester foetal livers and characterised by flow cytometry. fMSC stained positive for CD29, CD44, CD166, CD105, SH-3 and SH-4, and negative for CD14, CD34 and CD45. When plated on adipogenic, chondrogenic and osteogenic media, fMSC differentiated into the respective cell lineage. Compared to adult MSC (aMSC), the proliferative capacity of fMSC was higher. Mitogen stimulation of PBL was inhibited by fMSC. The greatest inhibition (78%) was seen when 30 000 fMSCs were added to 150 000 lymphocytes stimulated by phytohaemagglutinin. Adult and fMSCs were added to mixed lymphocyte cultures (MLC) containing peripheral blood lymphocytes or foetal liver cells. Unlike aMSC, fMSCs did not inhibit MLC. fMSC could be culture-expanded several million folds with no loss of phenotype characteristics, which makes them ideal for ex vivo expansion. fMSC inhibit lymphocyte proliferation induced by mitogens, but not alloreactivity as measured by MLC.
Haematopoiesis is a continuous self-renewing process in which mature cells are replaced by new ones that are derived from proliferation and differentiation of haematopoietic stem cells (HSCs). Haematopoiesis occurs under the influence of the microenvironment in the bone marrow, which consists of stroma cells derived from mesenchymal stem cells (MSCs). MSCs are nonhaematopoietic pluripotent cells present in bone marrow, which can differentiate in vitro to osteocytes, chondrocytes, adipocytes, tenocytes and stromal cells under certain conditions. 1, 2 The prevalence of MSC declines with advancing age. In a newborn marrow, one MSC is found among 10 000 nucleated marrow cells, as compared to one MSC per 250 000 nucleated marrow cells in the adult bone marrow. 3 MSCs are present in low numbers in term cord blood, 4 but the prevalence of MSC in foetal bone marrow, liver and first-trimester blood is much higher. 5 MSCs derived from adult persons express intermediate levels of HLA class I and low levels of HLA class II. 6, 7 They should therefore be recognised by allogeneic lymphocytes, but instead appear to possess an immunomodulatory effect in vitro and suppress the proliferation of activated lymphocytes 7, 8 (McIntosh, personal communication). The suppression is dose dependent and occurs regardless of the donor source, including 'third party' MSC, that is, cells obtained from neither a stimulator nor responder cell source. Similar findings were made in vivo, since infusion of allogenic, major histocompatibility mismatched MSC into baboons was well tolerated in most of these animals and prolonged the survival of skin allografts. 9, 10 It has been shown that MSCs produce alpha-l-iduronidase, arylsulphatase-A and -B, glucocerebrosidase and adrenoleukodystrophy protein. These cells can therefore be used for transplant in metabolic disorders, such as Hurler's disease. 11 Thus, MSC may have several interesting features that make them candidates as a source of donor cells for transplantations. Mackenzie and Flake 12 reported a generalised engraftment of human MSC after intrauterine transplantation in a sheep model, indicating that MSC may be suitable for intrauterine transplantations.
In the present study, we describe the isolation and expansion of MSC from first-trimester foetal livers that can differentiate in vitro along the osteogenic, chondrogenic and adipogenic lineages. Furthermore, we have examined the effect of foetal MSC (fMSC) on lymphocyte proliferation in mixed lymphocyte cultures and after mitogenic stimulation. This may have clinical implications for preand postnatal transplantations.
Materials and methods

Material
To isolate human fMSC, liver samples from six foetuses (median gestational age 9 weeks, range 6-10 weeks) aborted in the first trimester were collected, where patients had volunteered to donate foetal tissue. The study was approved by the Ethics Committee at Huddinge University Hospital. Written consent was obtained from all the patients. The abortions were performed with vacuum aspiration, as previously described in detail. 13 For isolation of adult MSC (aMSC), bone marrow aspirates of 10-20 ml were taken from the iliac crest of normal donors ranging in age from 9 to 47 years.
Isolation and culture of MSC from foetal livers
To form a single-cell suspension, foetal livers were disintegrated by passage through a 100 mm nylon filter. MSCs were isolated and cultured in accordance with an earlier technique reported elsewhere.
14 The cell suspension was diluted to a final concentration of 10 7 cells/ml. Mononuclear cells were separated by centrifugation at 500 Â g for 30 min at room temperature on a Percollgradient (density 1.073 g/ml, Amersham Pharmacia Biotech, Uppsala, Sweden). The interface was collected, resuspended in PBS and centrifuged at 500 Â g for 10 min at room temperature. The cells were suspended in Dulbecco's modified Eagles medium-low glucose (DMEM-LG) (Invitrogen, Paisley, Scotland) supplemented with 10% FCS (Sigma, St Louis, MO, USA) and 1/100 antibiotic-antimycotic solution (Invitrogen, Cat. No. 15240-062) and 1.6 Â 10 5 cells/cm 2 were plated in culture flasks. Cultures were maintained at 37 o C in a humidified environment containing 5% CO 2 . After 3 days, the nonadherent cells were removed and the medium replaced. The medium was changed every 3-4 days thereafter. At near confluence, the cells were detached by treating them with 0.05% trypsin and 0.53 mM EDTA (Invitrogen, Cat. No. 25300-062) and replated in a density of 4 Â 10 3 cells/ cm 2 in culture flasks. aMSCs from bone marrow were isolated and cultured, as described elsewhere in detail. 14 
Phenotype of cultured fMSC
For flow cytometry, cultured fMSC from passage's two to nine were harvested by treatment with trypsin-EDTA, as above. The detached cells were washed and resuspended in PBS in aliquots of 0.5 Â 10 6 cells. To identify surface epitopes, the cells were stained with fluorescein-conjugated antibody against CD29 (Coulter, Miami, FL, USA), CD44 (Immunotech, Marseilles, France), CD166, CD105 (also called SH-2), (Ansell, Bayport, MN, USA), SH3, SH4 (Osiris Therapeutics Inc., Baltimore, MD, USA), CD14, CD34 and CD45 (Becton Dickinson, San Jose, CA, USA) and incubated for 15 min in room temperature in the dark. The cells were washed and then resuspended in PBS.
Nonspecific fluorescence was determined by using equal aliquots of cell preparations incubated with rabbit-antimouse monoclonal antibodies (Becton Dickinson). Finally, the cells were analysed in a flow cytometer (FACSort, Becton Dickinson). aMSCs were stained for the abovementioned surface epitopes with the method described for fMSC.
Differentiative ability of fMSC
The ability of fMSC to differentiate along adipogenic, chondrogenic and osteogenic lineages was assayed, as previously described. 15 fMSCs were cultured in adipogenic medium; induction media: Dulbecco's modified Eagles medium-High Glucose (DMEM-HG) (Bio Whittaker, Verviers, Belgium), 0.05 U/ml penicillin, 0.05 mg/ml streptomycin (Invitrogen, Cat. No. 15140-122), 10% FCS, 0.5 mm 1-methyl-3-isobutylxanthine, 10 mg/ml insulin, 0.2 mm indomethacin and 1.0 mm dexamethasone (Sigma) or supportive media: DMEM-HG (Bio Whittaker), 0.05 U/ ml penicillin, 0.05 mg/ml streptomycin (Invitrogen), 10% FCS and 10 mg/ml insulin (Sigma). The cells were plated in a density of 2.1 Â 10 4 cells/cm 2 and the medium replaced every 3-4 days for three cycles alternating between induction and supportive media. Cells were stained with oil red O solution (Sigma) to measure the accumulation of neutral lipids in fat vacuoles.
To induce chondrogenic differentiation, 2.5 Â 10 5 MSCs were pelleted in polypropylene tubes and cultured in DMEM-HG (Bio Whittaker) with 0.05 U/ml penicillin, 0.05 mg/ml streptomycin (Invitrogen), 1/100 insulin-transferrin-sodium selenite media supplement (ITSS) (Sigma, Cat. No I-1884), 5.33 mg/ml linoleic acid, 1.25 mg/ml BSA, 0.17 mm ascorbate-2-phosphate, 0.1 mm dexamethasone (Sigma), 1 mm Na pyruvate (Fluka AG, Buchs, SC, USA) and 0.35 mM proline (ICN Biomedicals, Costa Mesa, CA, USA). Differentiation was induced by adding 0.01 mg/ml TGF-b 3 (R&D Systems, Minneapolis, MN, USA). The medium was replaced every two to 3 days for 21 days. Pellets were fixed in 10% formalin, embedded in paraffin, examined morphologically and stained for the presence of glucosaminoglycans with Alcian green.
For osteogenic differentiation, MSCs were plated in a concentration of 3.1 Â 10 3 cells/cm 2 and cultured in DMEM-LG medium supplemented with 0.05 U/ml penicillin, 0.05 mg/ml streptomycin (Invitrogen), 10% FCS, 0.05 mm ascorbic acid, 10 mm glycerophosphate and 0.1 mm dexamethasone (Sigma). The medium was changed every 3-4 days for 21 days. The cells were fixed in 10% formalin, embedded in paraffin, morphologically examined and then stained for the presence of mineral with the von Kossa method.
aMSCs were cultured in adipogenic, chondrogenic and osteogenic medium, using the method described above for fMSC.
Mixed lymphocyte cultures (MLCs) and mitogenic stimulation
Adult peripheral blood lymphocytes (PBLs) were prepared by centrifuging peripheral blood on a Ficoll gradient (Lymphoprep, Nycomed Pharma, Oslo, Norway) at 500 Â g for 20 min at room temperature. Lymphocytes
Foetal mesenchymal stem cells and alloreactivity C Götherström et al from two donors or lymphocytes pooled from five donors, were used as stimulator cells. This population had been irradiated with 20 Gy. These cells were cocultured with nonirradiated responder lymphocytes or foetal liver cells (FLCs) (median gestational age 15 weeks, range 7-18 weeks) from one donor. Triplicate samples of 1 Â 10 5 cells were cultured in 0.2 ml RPMI 1640 medium supplemented with 20 mm HEPES, 100 U/ml penicillin, 100 mg/ml streptomycin, 20 mm l-glutamine (Invitrogen) and 10% pooled human AB serum in 96 well plates.
To study how fMSC and aMSC affect lymphocyte and FLC alloreactivity, 100, 1000, 10 000 or 20 000 irradiated MSCs were added at the beginning of the experiment. The cultures were incubated at 371C in humidified 5% CO 2 air for 6 days. This method has been described elsewhere in detail. 16 The following mitogens were used to stimulate lymphocytes: concanavalin A (ConA) to a final concentration of 5 mg/ml (Amersham Pharmacia Biotech), phytohaemagglutinin (PHA) 9 mg/ml (Wellcome, Dartford, UK), purified protein A from Staphylococcus aureus (SpA) 10 mg/ml (Amersham Pharmacia Biotech) and poke weed mitogen (PWM) diluted 1/100 (Invitrogen, Cat. No. 15360-019). 17, 18 These were added to one population of 1.5 Â 10 5 lymphocytes supplemented with 1500, 15 000 or 30 000 irradiated MSCs and cultured, as described above for the MLC method.
On day 3 (ConA and PHA) or on day 5 (SpA, PWM and MLC), 1 mCi/ml 3 H-thymidine (Amersham Pharmacia Biotech, Little Chalfont, UK) was added for incorporation in DNA synthesis. After 24 h, the cells were harvested on a glass fibre filter (Wallac, Turku, Finland) using a semiautomatic harvesting machine (Harvester 96, Tomec, Orange, CT, USA). Radioactivity was determined as counts per minute (cpm) with an Intertechnique beta-counter (Wallac). Background cpm for each type of cell was derived using the same technique, but using cells cocultured with irradiated cells from the same person, with or without the various amounts of MSCs. For the mitogenic assay, stimulation was measured by adding the different mitogens to lymphocytes without adding MSC.
Results
MSC cultures from human foetal liver
MSCs were successfully isolated and in vitro expanded from six foetal livers. Before passage one, the cells grew regularly in well-demarcated colonies consisting of a few dozen to several hundred homogeneous cells. At a median of 13 days of culture, the cells had produced an adherent layer of spindle-shaped fibroblast-like cells (Figure 1a) .
The proliferative capacity of fMSC was higher than that of aMSC. As an example, from passage one to passage two, the number of aMSC increased 3.5 times, while the number of fMSC increased 12.3 times. In the time from passage three to passage four, the number of aMSC increased 2.6 times, whereas the number of fMSC increased 12.5 times (data not shown).
Phenotype of fMSC
fMSC cultured for two to nine passages consisted of a phenotypically homogeneous cell population when examined by flow cytometric analysis of surface antigens. The immunophenotypic profile of fMSC was similar to that previously described for aMSC. (Figure 2 ). aMSC were positive and negative for the same surface epitopes as fMSC. 8 In vitro differentiation of fMSC By culturing fMSC in adipogenic, chondrogenic and osteogenic conditions, we studied the differentiative potential of MSC derived from human foetal livers. When fMSCs were cultured in osteogenic media, they changed their morphology, from spindle-shaped to cubical cells. Mineralisation occurred in induced cultures, which was detected by staining with the von Kossa method (Figure 1b) . Chondrogenic differentiation was induced by adding TGF-b 3 . Formed pellets had chondrogenic morphology when stained with haematoxylin-eosin and alcian green for glucosaminoglycans (Figure 1c) . When plated on adipogenic media, fMSC underwent morphological changes and produced vacuoles containing lipid that could be detected with oil red O staining (Figure 1d ). Cells that had been cultured for more than six passages did not undergo adipogenic differentiation.
Effects of fMSC and aMSC on background PBL and background FLC
To determine whether fMSC and aMSC could induce a proliferative response by allogenic lymphocytes, PBLs were cultured with irradiated fMSC and aMSC in various doses. The response was measured as cpm, which corresponds to cell proliferation.
As shown in Figure 3a , no increase in lymphocyte proliferation was seen after addition of 1000 fMSCs to adult-derived lymphocytes. In contrast, slight lymphocyte proliferation was seen when higher concentrations of fMSCs were present in the culture.
Calculation of the median stimulation index (SI ¼ (cpm of PBL+MSC)/(cpm of PBL)) confirmed a small, but insignificant, increase in lymphocyte proliferation after addition of fMSCs. The SI after adding 1000 fMSC was 2.0 (range 0.8-7.7). The addition of 10 000 and 20 000 fMSC increased the SI to 4.0 (range 0.4-19.1) and 3.8 (range 0.3-22.5), respectively.
As shown in Figure 3b , the addition of aMSC to allogeneic lymphocytes induced little, if any, proliferation. SI ranged from 1.1 to 4.5 in the presence of various concentrations of aMSC.
When fMSCs were added to FLC, proliferation also increased in a dose-dependent way (Figure 4a) . Similarly, aMSC induced a dose-dependent response on background FLC in some experiments (Figure 4b ).
Effects of fMSC and aMSC on PBL alloresponses
To determine whether fMSC and aMSC affect the proliferation of lymphocytes in response to alloantigens, PBLs were stimulated with PBL from another person. The effect MSC elicit on lymphocytes was evaluated as cell proliferation cpm in the presence of various concentrations of MSCs compared to an identical MLC run in parallel without adding MSC. No suppression of proliferative responses was seen after adding fMSC (Figure 3a) . In some experiments proliferation was stimulated.
As described elsewhere, 8 suppression of proliferation in MLC occurred in a dose-dependent fashion when more aMSCs were added (10 000-20 000) (for a typical experiment, see Figure 3b ). With fewer numbers of aMSCs, the inhibitory effect was less consistent. The addition of 100-1000 aMSCs sometimes enhanced rather than inhibited the lymphocyte proliferation.
Effects of fMSC and aMSC on foetal mixed lymphocyte cultures with PBL as stimulators
We next examined if fMSC or aMSC could modulate foetal alloreactivity against adult PBL. When FLCs were stimulated with irradiated adult lymphocytes, there was no inhibition, but rather an increase in fMLCs after adding fMSC or aMSC (Figure 4a, b) .
Effects of fMSC on mitogenic stimulation
As shown in Figure 5 , the addition of fMSCs to PBL stimulated with ConA, PHA and SpA suppressed the mitogenic response in a dose-dependent fashion. For instance, the addition of 30 000 fMSC reduced PHA lymphocyte proliferation to 22% of control values, they also suppressed lymphocyte proliferation induced by PWM ( Figure 5 ). By adding 1500 and 15 000 fMSCs to lymphocytes stimulated with PWM, inhibition was seen in some and enhanced responses by fMSC were seen in other experiments.
Discussion
We report the isolation, characteristics and immunological properties of MSC derived from human first-trimester foetal livers. These cells had the characteristic features of Foetal mesenchymal stem cells and alloreactivity C Götherström et al aMSC. Mononuclear cells from foetal livers cultured in medium containing FCS readily generated adherent spindle-shaped cells. The proliferative capacity of fMSCs was significantly higher than that of aMSC. The fact that fMSCs show a considerable ability to grow ex vivo makes them ideal for transplantation purposes. The number of fMSCs can be increased several million fold in culture without loss of phenotype. Cells harvested at passage two to nine were positive for the typical aMSC markers 2 CD29, CD44, CD166, CD105 (SH-2), SH-3 and SH-4 and negative for CD14, CD34 and CD45. This confirms the findings about fMSC reported by Campagnoli et al. 5 We found that fMSC under appropriate culture conditions could be induced to differentiate in vitro to adipocytes, chondrocytes and osteocytes. However, the ability to differentiate into the adipogenic lineage declined after more than six passages in culture. This finding is similar to that reported by Campagnoli et al 5 on fMSC and Conget and Minguelly 19 on aMSC. The capacity to differentiate into chondrocytes and osteocytes was not affected by the number of passages in culture. As we have previously shown, aMSC cultured in adipogenic, chondrogenic or osteogenic medium differentiated into adipocytes, chondocytes and osteocytes, respectively. 8 Thus, the MSCs we have isolated from human foetal livers appear to share the phenotype and multilineage potential of MSCs present in adult bone marrow 2 and other foetal tissues. 5 Additionally, we have isolated hMSC from foetal lung and chorion. These foetal lung-and chorion-derived MSCs show features similar to the foetal liver-derived MSCs. fMSC did not elicit alloreactive T-cell proliferative responses in lymphocytes derived from adult donors. In contrast, proliferation of foetal cells was seen after adding foetal, but not adult, MSC. aMSC constitutively secrete a large number of cytokines and support the expansion of haematopoietic cells in vivo. 20 During foetal development, haematopoiesis occurs in the liver, which consists of a variety of cells that can respond and proliferate. Campagnoli et al 5 showed that fMSCs support proliferation and differentiation of cord blood cells in long-term culture. Thus, the increase in cell proliferation seen after addition of fMSCs to FLC may reflect proliferation of haematopoietic cells and hepatocytes rather than an immune response.
Adult bone marrow cells and murine MSC possess unique immunomodulatory properties and inhibit T-cell proliferation induced by nonspecific mitogens, cognate peptide as well as alloreactivity induced in MLC. 7, 8, 21 The mechanism behind the immunosuppressive effect of aMSCs is unknown. In a study on baboons, the addition of IL-2 to ConA-stimulated lymphocytes abrogated the suppression induced by MSC. 22 This indirect evidence suggests that the effect of MSC on mitogen-activated lymphocytes may be partly because of inhibition of IL-2. It is uncertain whether the same mechanism that inhibits mitogenic responses also Foetal mesenchymal stem cells and alloreactivity C Götherström et al inhibits alloreactivity in MLC and in vivo. In one study, the addition of antibodies against TGFb 1 and hepatocyte growth factor (HGF) reversed the suppression aMSC exert on purified T cells stimulated with PBL. 7 We have not been able to repeat these experiments using PBL as responding cells (data not shown).
In contrast to aMSC, fMSC did not suppress an alloproliferative response in PBL. However, PBLs activated by four types of mitogens were inhibited by the presence of fMSC in the cultures. The most marked inhibitory effect was seen with PHA and SpA. PHA activates T cells, 17 SpA activates T-and B-cells. 18 Less suppression occurred after activation with the T-cell mitogen ConA 17 and PWM, which induces T-cell dependent B-cell stimulation. 23 This discrepancy of fMSC with an ability to suppress lymphocyte proliferation induced by mitogens but not the polyclonal, polyepitope MLC could be because of immunologic immaturity during the end of the first trimester. Immunocompetence develops in the human foetus beginning at the end of the first trimester. We have found that FLCs can respond in MLC to a varying degree from the eighth gestational week. 24 However, since fMSCs suppress the proliferation induced by mitogens, it appears that they, at least possess some of the immunomodulatory properties found in aMSC. To conclude, fMSCs were successfully grown in culture. The cells have morphologic and immunophenotypic characteristics similar to those of adult-derived MSC and can be induced to differentiate into adipocytes, chondrocytes and osteocytes. fMSCs did not elicit alloreactive T-cell proliferative responses. Furthermore, the fMSC inhibited mitogen-stimulated lymphocytes, but not lymphocytes in MLC. These findings may have implications for intrauterine transplantation in haemoglobinopathies, inborn errors of metabolism and mesenchymal cell related disorders. [25] [26] [27] [28] [29] [30] [31] [32] Additional studies are needed to determine the mechanism underlying the effect MSCs have on lymphocyte proliferation.
